Security key
G6724L116
OKYO Pharma Ltd - Ordinary Shares, no par value (OKYO)
CUSIP: G6724L116
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Ordinary Shares, no par value
- Shares outstanding
- 52,174,143
- Total 13F shares
- 1,010,912
- Share change
- +97,330
- Total reported value
- $1,210,177
- Price per share
- $1.20
- Number of holders
- 7
- Value change
- +$115,592
- Number of buys
- 2
- Number of sells
- 2
Report period
Q2 2024
Institutions
7
Top holders
7
OKYO full security history
Newer quarter: Q3 2024
Previous quarter: Q1 2024
OKYO Pharma Ltd SEC filings
OKYO Pharma Ltd company facts
Broader feeds
Reporting periods
Holder history for CUSIP G6724L116
Recent filing periods:
Top shareholders of OKYO - OKYO Pharma Ltd - Ordinary Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BARCLAYS PLC |
13F
|
Company |
1.6%
|
855,887
|
$1,275,272 | — | 31 Mar 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.04%
|
20,310
|
$30,465 | — | 31 Mar 2024 | |
| Cerity Partners LLC |
13F
|
Company |
0.03%
|
13,312
|
$19,834 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.02%
|
12,090
|
$18,135 | — | 31 Mar 2024 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.02%
|
11,933
|
$20,286 | — | 31 Mar 2024 | |
| Continuum Advisory, LLC |
13F
|
Company |
0%
|
50
|
$76 | — | 31 Mar 2024 | |
| John P. Brancaccio |
3/4/5
|
Director |
—
class O/S missing
|
16,670
|
$25,005 | — | 15 Sep 2023 |
Institutional Holders of OKYO Pharma Ltd - Ordinary Shares, no par value (OKYO) as of Q2 2024
As of 30 Jun 2024,
OKYO Pharma Ltd - Ordinary Shares, no par value (OKYO) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,010,912 shares.
The largest 7 holders included
BARCLAYS PLC, Cerity Partners LLC, GEODE CAPITAL MANAGEMENT, LLC, HSBC HOLDINGS PLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, UBS Group AG, and Continuum Advisory, LLC.
This page lists
7
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
6
Q2 2024 holders
7
Holder diff
1
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.